First AD

Second AD

Assessing Transplant Eligibility and Fitness for Intensive Chemotherapy

Video content above is prompted by the following:

Please describe how you identify individuals eligible for allogeneic transplant.

Discuss when you begin the process of referring a patient for transplant.

How do you determine if a patient is fit for intensive chemotherapy induction in the frontline setting?

What are some criteria that you use to determine if patients are eligible for intensive chemotherapy induction?

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


Insights

Insights is an expert interview video series of leading oncologists that provides in-depth reports and feature segments profiling leaders in a range of oncology disciplines, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecologic cancers, and hematologic malignancies. Most episodes feature 2 clinicians discussing the latest oncology advances in clinical practice. 

Video Series

Optimizing Intensive Chemotherapy Management in Secondary AML Through Academic Community Collaboration 

Panelists discuss how identifying candidates for allogeneic transplant in secondary acute myeloid leukemia  involves a comprehensive assessment of disease characteristics, patient factors, and timing considerations, while also evaluating fitness for intensive chemotherapy induction using specific criteria to guide treatment decisions.